HEIDELBERG, Germany – This is the initial Europe Regional Medical Command H1N1 update. Periodic updates will include information about vaccine arrival, distribution and vaccination schedules.
- Vaccine expected in Europe early November 2009 in stages.
Availability will be widely publicized.
- Supplies may not be available all at once. Call your clinic to check.
- There are two separate types of vaccine
- One is earmarked for non-uniformed beneficiaries.
- The other is for uniformed personnel.
- Vaccine for non-uniformed beneficiaries is an inactivated, injectable vaccine
Manufactured by Sanofi-Pasteur, it is approved for ages 6 months and older. Target groups for vaccination include (all are equal in priority):
- Pregnant women
- Beneficiaries 6 months-24 years old.
- Caregivers/families of babies < 6 months old.
- People 25-64 years old with medical conditions that put them more at risk.
- Children 6 months to 9 years old will need to get two doses, separated by 4 weeks, to fully protect them.
- Vaccine will be given to all TRICARE beneficiaries and DoD employees.
- Vaccine for uniformed beneficiaries is an inactivated, injectable vaccine manufactured by Novartis.
Priority is deployed or deploying service members, direct healthcare providers, then all other active duty and 7th CSC Reservists.
- Novartis and Sanofi-Pasteur are licensed suppliers of seasonal influenza vaccines, and use the same manufacturing processes and quality testing procedures for H1N1 vaccine.
- Hand hygiene/respiratory etiquette is key for prevention.
For more information about H1N1 visit these Web sites:
ERMC H1N1 Web page
http://ermc.amedd.army.mil
Centers for Disease Control and Prevention
www.cdc.gov
Dept. of Health and Human Services
www.flu.gov
European CDC
www.ecdc.europa.eu
| 
HOME
FAQ
CONTACT US
LINKS
MEDCOM A-Z 
ARMY.MIL 
